Jeffrey B. Mirviss - 09 Dec 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP&Pres, Periph Intervent
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 09 Dec 2022
Net transactions value: -$1,506,349
Form type: 4
Filing time: 12 Dec 2022, 15:26:49 UTC
Previous filing: 05 Dec 2022
Next filing: 13 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$387,155	+29,599	+27%	$13.08	140,591	09 Dec 2022	Direct	F1
transaction	BSX	Common Stock	Sale	$1,893,504	-41,032	-29%	$46.15	99,559	09 Dec 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-29,599	-100%	$0.000000^*	0	09 Dec 2022	Common Stock	29,599	$13.08	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.97 to $46.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.